Status:
RECRUITING
Leveraging Artificial Intelligence and Multi-Omics Data to Predict Opioid Addiction
Lead Sponsor:
University of California, San Diego
Collaborating Sponsors:
VA Palo Alto Health Care System
San Diego Veterans Healthcare System
Conditions:
Opioid Use Disorder
Addiction, Opioid
Eligibility:
All Genders
18+ years
Brief Summary
The primary goal of this proposal is to validate a novel genomic and microbiome predictive model that may be used to assess a person's risk of developing opioid use disorder (OUD). The following will ...
Detailed Description
The primary goal of this proposal is to validate a novel genomic and microbiome predictive model that may be used to assess a person's risk of developing opioid use disorder (OUD). The following will ...
Eligibility Criteria
Inclusion
- diagnosis of OUD (active or in remission) defined by the DSM-5 criteria
- age ≥ 18 years old
Exclusion
- inability to participate independently with the study (i.e. dementia)
- chronic opioid use that is not consistent with a diagnosis of OUD
- patients that are pregnant
- children
- institutionalized individuals
- non-English speaking subjects as there are several surveys without appropriate translation and with sensitive information (e.g., questions about mental health and history of drug use) that is required to complete the study.
Key Trial Info
Start Date :
August 26 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2027
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06540105
Start Date
August 26 2024
End Date
September 30 2027
Last Update
September 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Diego
La Jolla, California, United States, 92037